1. Home
  2. IDYA vs FRMI Comparison

IDYA vs FRMI Comparison

Compare IDYA & FRMI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo IDEAYA Biosciences Inc.

IDYA

IDEAYA Biosciences Inc.

HOLD

Current Price

$36.76

Market Cap

3.6B

Sector

Health Care

ML Signal

HOLD

Logo Fermi Inc.

FRMI

Fermi Inc.

HOLD

Current Price

$4.53

Market Cap

3.2B

Sector

Real Estate

ML Signal

HOLD

Company Overview

Basic Information
Metric
IDYA
FRMI
Founded
2015
2025
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Real Estate Investment Trusts
Sector
Health Care
Real Estate
Exchange
Nasdaq
Nasdaq
Market Cap
3.6B
3.2B
IPO Year
2019
2025

Fundamental Metrics

Financial Performance
Metric
IDYA
FRMI
Price
$36.76
$4.53
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
16
8
Target Price
★ $52.86
$26.13
AVG Volume (30 Days)
661.4K
★ 14.0M
Earning Date
05-06-2026
05-13-2026
Dividend Yield
N/A
N/A
EPS Growth
★ 61.90
N/A
EPS
N/A
★ N/A
Revenue
★ $218,710,000.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
$201.05
$120.76
P/E Ratio
★ N/A
N/A
Revenue Growth
★ 3024.43
N/A
52 Week Low
$26.05
$4.43
52 Week High
$42.68
$32.39

Technical Indicators

Market Signals
Indicator
IDYA
FRMI
Relative Strength Index (RSI) 41.90 36.48
Support Level $34.74 N/A
Resistance Level $38.37 $7.65
Average True Range (ATR) 1.28 0.30
MACD -0.28 -0.01
Stochastic Oscillator 29.25 2.03

Price Performance

Historical Comparison
IDYA
FRMI

About IDYA IDEAYA Biosciences Inc.

IDEAYA Biosciences Inc is an oncology-focused precision medicine company committed to the discovery and development of targeted therapeutics for patient populations selected using molecular diagnostics. Its approach integrates small molecule drug discovery with extensive capabilities in identifying and validating translational biomarkers to develop targeted therapies for select patient populations that are likely to benefit from these targeted therapies. The company's clinical-stage product candidates include darovasertib (PKC), IDE397 (MAT2A), IDE849 (DLL3), IDE275 (Werner Helicase), IDE161 (PARG), and IDE705 (Pol Theta Helicase). In addition, it also working on other development candidates and has multiple earlier-stage preclinical programs.

About FRMI Fermi Inc.

Fermi Inc develops next-generation private electric grids that deliver redundant power at gigawatt scale to support next-generation intelligence and AI compute. It combines cutting-edge technology with a deep bench of world-class, multidisciplinary leaders with a combined 25 GW of experience to create one of the world's 17 GW next-gen private grids, helping ensure America's energy and AI dominance. The behind-the-meter Project Matador campus is expected to integrate the nation's combined-cycle natural gas project, one of the clean, new nuclear power complexes in America, utility grid power, solar power, and battery energy storage, to support hyperscale AI and computing.

Share on Social Networks: